Concepedia

Ming Hou

MH

Statistics

Publications

23

Citations

1.2K

H-Index

18

Active since

2003

Affiliations

Qilu Hospital of Shandong University(Current)

Shandong University

Sichuan University

Chinese Academy of Medical Sciences & Peking Union Medical College

Huazhong University of Science and Technology

Ming Hou is an author at Qilu Hospital of Shandong University specializing in medicine, cell biology, and radiation oncology.

ORCID

Top concepts

Publications per year

2003–2022

23

Publications

23

Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial

Yuankai Shi, Hang Su, Yongping Song et al. · The Lancet Haematology · 2019 · 233 citations

, , +2

Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma

Jie Xiong, Bowen Cui, Nan Wang et al. · Cancer Cell · 2020 · 228 citations · Full text

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

Jianxiang Wang, Zhixiang Shen, Giuseppe Saglio et al. · Blood · 2015 · 108 citations · Full text

Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial

Mei-feng Li, Xiaoli Li, Kai-liang Fan et al. · Journal of Hematology & Oncology · 2017 · 69 citations · Full text

Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial)

Li Chen, Hongming Zhu, Yan Li et al. · Proceedings of the National Academy of Sciences · 2021 · 59 citations · Full text

1–5 of 23